Marta
Llanos Muñoz
Part Time Assistant Professor (Health Science)
![Foto de Josep](/img/nophoto.png)
Josep
Tabernero Caturla
Publications by the researcher in collaboration with Josep Tabernero Caturla (8)
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2012
-
First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103
-
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Oncologist, Vol. 17, Núm. 1, pp. 15-25
-
Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
PLoS ONE, Vol. 7, Núm. 10
1995
-
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer
Breast Cancer Research and Treatment, Vol. 34, Núm. 1, pp. 15-24
1994
-
Chop chemotherapy of intermediate and high-grade non-hodgkin's lymphoma
Acta Oncologica, Vol. 33, Núm. 8, pp. 935-939
1993
-
False elevations of alpha‐fetoprotein associated with liver dysfunction in germ cell tumors
Cancer, Vol. 72, Núm. 8, pp. 2491-2494
-
METASTASIS BILATERAL DE MAMA DE FIBROHISTIOCITOMA MALIGNO
Oncologia, Vol. 16, Núm. 3, pp. 70-74